August 28, 2020 - Thermo Fisher Scientific Inc. (Boston, MA) announced that it has officially cut the ribbon on its new $40 million facility in Lenexa, Kansas, dedicated to viral transport media (VTM) production. The company also announced that the site will continue to expand to meet expected sustained demand for COVID-19 testing. Thermo Fisher says the facility has … [Read more...]
Thermo Fisher Scientific signs companion diagnostic agreement with Hengrui Therapeutics
August 17, 2020 - Thermo Fisher Scientific signed a companion diagnostic (CDx) agreement with Hengrui Therapeutics, Inc. (HTI), a U.S. subsidiary of Chinese pharmaceutical company Jiangsu Hengrui Medicine Co., Ltd. (JHM), to develop a CDx that will leverage the Oncomine Precision Assay, which runs on the new Ion Torrent Genexus System. Once commercialized, the CDx will be … [Read more...]
Thermo Fisher terminates proposed acquisition of QIAGEN
August 13, 2020 - Thermo Fisher Scientific Inc. (Waltham, MA) announced that its offer to acquire all of the ordinary shares of QIAGEN N.V. has lapsed. Based on information provided by the settlement agents for the offer, the minimum acceptance threshold condition to the offer was not satisfied and the offer has lapsed in accordance with its terms. As a result, Thermo … [Read more...]
Thermo Fisher develops COVID-19 antibody assay for transplant community
August 10, 2020 - Thermo Fisher Scientific (Waltham, MA) has developed a new serological assay targeted towards transplant candidates and recipients that can detect antibodies directed against COVID-19 (SARS-CoV-2). The assay will be provided under the company's One Lambda brand. In collaboration with histocompatibility, infectious disease and nephrology laboratories at … [Read more...]
Thermo Fisher Scientific launches nProber IV nanoprober platform
July 30, 2020 - Thermo Fisher Scientific (Waltham, MA) released the Thermo Scientific nProber IV nanoprober platform, a fault isolation system used by semiconductor fabs to precisely locate and characterize the nanometer-scale electrical faults that impact device performance and reliability. The nProber IV is the most advanced of Thermo Scientific's leading nProber systems, … [Read more...]
Thermo Fisher Scientific, Lyell Immunopharma form cell therapy manufacturing partnership
July 28, 2020 - Thermo Fisher Scientific Inc. and Lyell Immunopharma, a biotechnology company, are partnering to develop manufacturing processes designed to create more effective cell therapies to benefit cancer patients. The companies will work together to improve the fitness of T cells and Thermo Fisher will support Lyell in its development of an integrated yet flexible … [Read more...]
Thermo Fisher Scientific Expands GlobalAccess Sequencing Program
July 27, 2020 - Thermo Fisher Scientific (Carlsbad, CA) is expanding its GlobalAccess Sequencing Program to include laboratories working in oncology. Originally introduced to accelerate multi-institutional-led studies focused on SARS-CoV-2 (the virus that causes COVID-19), the expanded program now provides support to “labs facing significant constraints as a result of the … [Read more...]
Thermo Fisher receives FDA approval for blood test for identifying novel allergic sensitization to red meat
July 23, 2020 - Thermo Fisher Scientific (Boston, MA) announced that the ImmunoCAP Specific IgE alpha-Gal Allergen Component test was cleared by the U.S. Food & Drug Administration (FDA) for in vitro diagnostic use. The company says that the test results can aid specialists and other healthcare providers as they diagnose a patient's sensitization to the alpha-Gal … [Read more...]
Thermo Fisher Scientific’s response to COVID-19 continues to expand to support development, production of therapeutics, vaccines
July 20, 2020 – Thermo Fisher Scientific Inc. (Waltham, MA) continues to expand global capacity and capabilities across its pharma services network to support customers in government, industry and academia as they accelerate development and production of COVID-19 vaccines, therapies and other treatments. The company is now supporting more than 200 of these projects … [Read more...]
Thermo Fisher Scientific, First Genetics JCS partner to develop next-gen sequencing-based diagnostics in Russia
Thermo Fisher Scientific (Waltham, MA) and First Genetics JCS (Russia) announced a strategic partnership focused on commercializing next-generation sequencing (NGS)–based diagnostics in Russia. The agreement enables First Genetics to market its F-Genetics NGS System and IVD assays to Russian labs for reproductive health testing and cancer diagnostics. The F-Genetics System … [Read more...]